ARCHIVES

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

This article is from The Cancer Letter archive.

Vol. 36 No. 14 | April 16, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Detection Concept Was For Grants, Not Contracts; Wallens Gets Five Years Probation

November 16, 1984

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993